• 

Road industry is evolving in terms of infrastructure with new constructions and designs for sustainability. The concept of green infrastructure inspires construction of various road infrastructure like asphalt paved roads. This surges the demand for asphalt additives. Latest Fact.MR report predicts asphalt additives market to amount US$5.4Bn by the end of year 2027 owing to the accelerated consumption of asphalt additives for road constructions. Different highway agencies use asphalt additives for its positive attributes like improved adhesion and enhanced mixture durability which extends the life of pavements for few more years.

Increased highway life span increases demand

Extended highway life span bolsters the demand for asphalt additives like rejuvenators and bitumen. Bio-based additives like bio asphalt binders are the latest entrants in market that are generating plethora of opportunities in the global market. Fact.MR report states that global asphalt additives market is expected to expand at 5% CAGR during the forecast period 2019-2027.

The most commonly used material for paving is hot/warm mix. It is expected to dominate the global market owing to its benefits like low fuel consumption and reduced harmful emissions. Fact.MR report projects the demand for hot/warm mix to increase in Asia Pacific by 1.8 times of the current capacity in the forecast period. Its increasing consumption generates attractive opportunities for hot/warm mix additives that are expected to bring in sustainability in near future.

Get the Report Sample: https://www.factmr.com/connectus/sample?flag=S&rep_id=4413

Sustainable future is important

The world is growing towards creating a sustainable environment for future and stake holders in the construction industry are taking an active part in it. Public agencies and government are encouraging construction that are eco-friendly and sustainable. This has compelled different end-user industries to shift their focus towards bio-based additives. Roofing sector is gaining momentum and is increasing the demand for different sustainable construction components that are either bio-based or recycled. Eco-friendly asphalt additives are also highly demanded in the roofing industry. Gulf countries are progressively advancing towards adopting these eco-friendly components. Its Ministry of infrastructure has introduced road projects that use sustainable products like recycled rubber. These projects are initiated to achieve different goals like sustainability, innovation, recycling and establishing a network of green roads.

The competitive landscape of global asphalt additives market is moderately consolidated. Major stake holder in the market are expanding their business to get a greater hold of the market. Dow Chemical and Evonik are two of the major players in the market that are focused to expand their current facilities across the globe. Asia Pacific is their target as it offers benefits in terms of economy and opportunities to scale business. Players are introducing innovations in products for road construction with help of recycled materials. Evonik Industries introduced VESTENAMER® which is a cost-effective and sustainable form of asphalt additives. It is used as catalyst in rubber powder production form scrap tires. This powder is used to manufacture asphalt additives. Golden Gate Capital collaborated with Arkema Group to work on sustainable road development and invested $570Mn for this.

Request for the Report Customization: https://www.factmr.com/connectus/sample?flag=RC&rep_id=4413

• 

Food culture market is presumed be an evolving market. Different companies in the global market are leveraging different competitive aspects like cost-effectiveness, value addition and taste enhancement in food. This makes the competitive landscape very intense. Different types of food products including lactose-free and plant-based food products are highly demanded in market. Food products rich in probiotic also surge the food culture market. Latest Fact.MR report predicts the global food culture market to exceed the value of US$2.4Bn by the end of year 2027. Technological advancements and scientific advances have popularized bio-protection techniques in starter cultures. These techniques allow the producers in the global market to enhance the shelf life of different food products that can be easily stored and consumed.

Yeast and bacteria preferred for food culture

Regions like Europe and North America are witnessing increased production of dairy products like curd. Demographic shift is observed towards authentic and organic food products that are laced with all the safety criteria. Fact.MR report projects that the global food cultures market will grow at 7.2% CAGR during the forecast period 2019-2027.

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4414

Several industries that deal in fermented food use yeast and bacteria to research on food culture starters. Both bacteria and yeast are known to own 85% of the global market share. Their application in fermented food is on the basis of their positive attributes like enhanced shelf life and longevity. The application has significantly grown in the recent years owing to the accelerating demand for fermented food. Fermented food is primarily demanded by people in western countries for its taste and unique flavors. Major stake holders have acknowledged this growth in demand and are introducing new and different taste and flavors in the food products to gain a greater market penetration.

Europe leads global market in expenditure

Fact.MR report highlights the fact that Europe led the global food cultures market with one-third of the total expenditure in the global market in the year 2018 owing to the enhanced dairy production and easy governing regulations. Asian countries exhibit promising future in food cultures market in the forecast period on the backdrop of major market players concentrated in its developing regions like India and China. Producers in the global market are making huge investments in latest technologies to suffice the growing demand in these regions. One of the US-based companies named DuPont increased the capacity of its plant in Beijing by 112% to gain a greater foot hold in the region.

Global food cultures market has been highly unorganized till date. Foreign firms are now investing in the markets of developing nations. Major players of food culture market are conducting R&D to come up with great products. Chr. Hansen launched a unique type of first culture that aids the producers to create naturally sweet products. DuPont introduced culture for fermented food that are plant-based. They claim that their new ingredient has the potential to extend the shelf life of food products and beverages that are based on fermented food and plants.

Get Free Custom Research Quote: https://www.factmr.com/connectus/sample?flag=RC&rep_id=4414

• 

Global Spray Drying Equipment Market – A Report by Fact.MR

Fact.MR, in its latest business intelligence study, depicts the nuts and bolts of the global spray drying equipment market. The spray drying equipment market report presents detailed information regarding the drivers, restraints, opportunities and trends affecting market growth. Each segment along with its sub-segment is analyzed in terms of value and volume. Further, the spray drying equipment market report elaborates the market behavior of each vendor operating in the spray drying equipment market.

Increasing penetration of automation in spray drying equipment is creating attractive and tangible opportunities for prominent manufacturers, helping the spray drying equipment market register a modest CAGR of 4% over the forecast period (2019-2027). High energy output in large as well as mobile spray dryers is maximizing sales of global spray drying equipment.

The availability of a large number of spray dryers and their suitability for all material variants has resulted in significant demand from end-use industries. In addition, spray dryers are showcasing maximum penetration among the various types of industrial dryers and account for around 1/3rd of overall sales among industrial dryers.

Key spray drying equipment manufacturers are highly focused on adopting China plus one strategy by expanding their sales footprint outside China, mainly in India and ASEAN countries. Also, an increasing number of end-use industry projects in India and ASEAN countries will bolster the sales of global spray drying equipment market by 1.3x over the forecast period.

In addition, with OEMs and aftermarkets playing a pivotal role in the spray drying equipment market, manufacturing of spray dryers will catalyze growth prospects for manufacturers in global spray drying equipment market. Furthermore, economic imbalance and volatility in the industrial automation sector have thwarted the growth of the spray drying equipment market over the historical period, however, the long-term outlook seems promising across different verticals.

The spray drying equipment market report considers the following years to present the overall market growth:

• History Year: 2013-2018
• Base Year: 2013
• Estimated Year: 2027
• Forecast Year: 2019 – 2027

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=4418

Key findings of the spray drying equipment market study:

• Regional breakdown of the spray drying equipment market based on predefined taxonomy.
• Innovative manufacturing processes implemented by spray drying equipment market vendors in detail.
• Region-wise and country-wise fragmentation of the spray drying equipment market to grasp the revenue, and growth outlook in these areas.
• Changing preferences among consumers across various regions and countries.
• Factors (Positive and Negative) impacting the growth of the global spray drying equipment market.

On the basis of type, the spray drying equipment market study consists of:

• Rotary Atomizer
• Nozzle Atomizer
• Fluidized
• Centrifugal
• Closed Loop

On the basis of end use industry, the spray drying equipment market study incorporates:

• Food & Beverage
• Chemical
• Pharmaceutical

On the basis of region, the spray drying equipment market study contains:

• North America (U.S., Canada)
• Latin America (Brazil, Mexico)
• APAC (India, Japan)
• MEA (South Africa, Israel)

Key players analyzed in the spray drying equipment market study:

• GEA Group AG
• SPX Flow Technology
• Buchi Labortechnik AG
• Dedert Corporation
• European Spray Dry Technologies LLP
• AVM Technologies
• Shandong Shungeng Drying Equipment Co. Ltd.
• E. Rogers
• Labplant
• Swenson Technology
• Yamato Scientific America
• Acmefil

Queries addressed in the spray drying equipment market report:

• How has the global spray drying equipment market grown over the historic period of 2013-2018?
• Why are the spray drying equipment market players targeting region for increased product sales?
• What patented technologies are the players utilizing in the global spray drying equipment market?
• Which regions are displaying the fastest growth in the spray drying equipment market?
• What are the underlying micro- macroeconomic factors affecting the global spray drying equipment market?

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=4418

Why choose Fact.MR?

Reports published by Fact.MR are a result of the combination of our experts and digital technologies. We thrive to provide innovative business solutions to the clients as well as tailor the reports aligning with the clients’ requisites. Our analysts perform comprehensive research to offer ins and outs of the current market situation. Clients across various time zones tend to utilize our 24/7 service availability.

• 

ENT surgical devices market is expected to surpass US$ 2,500 million in 2019, according to a new study by Fact.MR. The ENT surgical devices market witnessed a steady progress and grew at 6.6% y-o-y in 2018. Overall growth of the ENT surgical devices market can be attributed to,

• Technological advancements enhancing ENT procedure efficiency and outcome
• Reimbursement policies in favor of ENT surgeries
• Product developments accommodating demand trend such as minimal invasion

The medical technology industry has shifted from a traditional marketing model to a care delivery model. Following the new business approach, Tier 1 and Tier 2 players portray hegemony in the market and continue to introduce disruptive technology innovations in ENT surgical devices.

The ENT surgical devices marketplace has the presence of a broad range of surgical instruments and equipment. According to Fact.MR valuation, ENT surgical lasers account for a leading share in the global market.

Greater reliability of the laser treatment in ENT or otorhinolaryngology has been embraced by medical professionals as well as patients. Ranging from the treatment of snoring or nasal obstruction to cancer of ear, nose and throat, laser therapy have delivered definitive results and the account of successful outcomes is rising consistently.

Fact.MR estimates that powered ENT surgical system will also register considerable demand in 2019. Powered ENT instruments are used in procedures such as removal of soft tissue, hard tissue and bone during surgery. On the other hand, the ENT visualization systems are growing at a faster pace and over 9% y-o-y growth is expected in 2019.

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=2454

The ENT surgical devices marketplace has witnessed introduction of a number of advanced navigation system, in particular, three-dimensional guiding system. Leading ENT surgical device manufacturers have introduced advanced navigation systems that assist ENT surgeons in easier navigation during ENT surgeries.

Hospitals Held Over Half the Revenues in 2018, ENT Clinics Growing Rapidly

Fact.MR valuation finds that the ENT surgical devices market hit US$ 2,345 million in 2018 and the growth trend will continue in 2019. Hospitals continued to capture greater market share of the ENT surgical devices market in 2018. Improved hospital infrastructure with well-equipped ENT instruments can be attributed to over half the global share of hospitals in the ENT surgical devices market.

In consonance with the rising prevalence of ENT disorders, construction of specialized ENT clinics has increased. Fact.MR finds that ENT clinics hold the second largest revenue and will grow at a faster rate in 2019.

Fixed ENT Surgical Devices to Hold Over 37% Revenue Share in 2019

Based on modality, three types of devices are present – handheld, portable and fixed. Owing to the popularity of fixed devices, Fact.MR estimates that these devices will continue to account for a higher market share. On the other hand, handheld devices are estimated to account for the second largest revenue in the ENT surgical devices market and will register faster expansion in the coming years.

According to the study, North America dominates the ENT surgical devices market and will account for over one forth revenue share in 2019. The market growth in North America is favored by favorable healthcare reimbursement coverage. In addition, presence of industry leaders in the regions contributes to the higher market revenues.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=2454

The study finds that Europe follows North America with the second largest revenues. Europe and APEJ collectively held over half the revenues in 2018. While Europe presents an established market, improving healthcare infrastructure and economic standards in APEJ can be attributed to the growth scenario of the ENT surgical devices market in the coming years.

• 

According to a recent study of Fact.MR, the natural cold, cough, and sore throat remedies market is expected to surpass revenues worth US$ 4,800 Mn in 2019. The rising popularity of alternative medicine and therapies, coupled with the widespread adoption of natural medication in healthcare worldwide are key factors that are fueling growth of the natural cold, cough, and sore throat remedies market.

The study opines that natural syrups and drops will continue to hold nearly half share of the market, accounting for revenues worth over US$ 2,200 Mn in 2018. The palatable taste of syrups and the presence of multiple ingredients deemed to boost the overall immunity, while combating cold and cough, are pivotal reasons behind increased traction for natural syrups & drops. For instance, sales of Nin Jiom Pei Pa Koa, a Chinese herbal syrup for treating cough, witnessed a significant surge in sales in the US during the flu season in 2018, not only because it was effective but also because consumers found the syrup’s taste surprisingly pleasant.

Inclusion of natural ingredients, such as cinnamon, cloves, raw honey, and turmeric in syrups, which are traditionally commended to boost the overall immunity of individuals, continue to attract consumers.  Furthermore, consumer testimonials praising natural remedies for their effectiveness and safety are bolstering the growth of the market.
Growing Consumer Demand for Natural Cold Remedies Prompt Hospital Pharmacies to Expand their Portfolio.

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=2988

A marked consumer shift towards naturally-derived medicines and therapies, coupled with the growing concerns regarding the health impacts of conventional medicine, has prompted hospital pharmacies to include more natural products for the treatment of cold and cough. Government efforts to promote the integration of natural medicine in healthcare has underpinned the growth of the trend. A notable development that alludes to the growth of the pervasive trend was a 9% increase in the investment on homeopathy by the Scottish government in 2017. The study estimates hospital pharmacies to account for over 40% share of the natural cold, cough, and sore throat remedies market in 2019.

Sales from e-commerce are expected to grow at a comparable rate with hospital pharmacies, as retailers shift their focus on leveraging analytics to develop targeted marketing strategies. Moreover, the increasing consumer preference for self-medication, coupled with the convenience offered by e-commerce, is further expected to aid retailers in gaining more value from the online sales.

According to the study, opportunities are abundant for key players in the natural cold, cough and sore throat remedies market in Asia-Pacific excluding Japan (APEJ). Deep-rooted traditional beliefs about the effectiveness of natural substances in the treatment of health ailments, and easy accessibility to raw materials for the production of natural remedies, are vital growth determinants for the market players in the region.

There have been various government initiatives in the region to promote use of natural medications for cold, cough and sore throat. For instance, the Indian government formed the Ministry of AYUSH to streamline production of Ayurvedic medicines and naturopathy. China, on the other hand, allows commercial sales of herbal medicines without the requirement for approval from the Chinese Food and Drug Administration. Following India and China’s lead, Japan decided signed a pact with India to promote cooperation in the field of Ayurveda. With more such initiatives in the pipeline, growth of the natural cold, cough, and sore throat remedies market in APEJ will remain robust.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=2988

The Fact.MR report tracks the natural cold, cough, and sore throat remedies market for the period 2018-2028. According to the report, the natural cold, cough, and sore throat market is projected to grow at 6.5% CAGR through 2028.

• 

According to a new study of Fact.MR, the gonorrhea therapeutics market will reach ~US$ 970 Mn in 2019, and estimated to register a 4% Y-o-Y over 2018. The gonorrhea therapeutics industry will remain influenced by increased attention on new developments in novel therapeutic compounds or antimicrobials for improving the success potential of future treatment.

There has been a significant rise in the prevalence of gonorrhea that is resistant to components of dual antibiotic therapy – ceftriaxone and azithromycin, which is the only recommended treatment for gonorrhea. In addition, resistance to several other antibiotics apart from dual antibiotic therapy resulted in ‘super gonorrhea’, which has become a buzzword in the gonorrhea therapeutics market. With a slew of promising new antibiotics on the horizon, alongside surveillance, education and preventative measures to stymie prevalence of super-resistant gonorrhea, prospects seem bullish for the gonorrhea therapeutics market.

“As gonorrhea, a sexually transmitted bacterium is increasingly learning to withstand the currently available antibiotics, the infection is making progress in its relentless march towards untreatable status. Growing partnerships between companies and organizations, to develop novel drugs that combat the drug-resistant gonorrhea, are highly likely to complement gains in the market,” says Fact.MR report.

Dual Therapy Remains the Treatment of Choice

The market of gonorrhea therapeutics is likely to grow in parallel with the potentially effective drugs that are currently in pipeline. Growing number of clinical trials and rising investments in healthcare industry will continue to pave lucrative avenues of growth for the gonorrhea therapeutics market. The study opines that dual therapy will remain the treatment of choice for gonorrhea, accounting for ~90% market shares. This falls in line with the current recommended regimen for gonorrhea treatment that includes a combination of two antibiotics, azithromycin, which is given orally, and ceftriaxone, an intra-muscular drug.

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=3761

Preveiw Analysis of Global Gonorrhea Therapeutics Market research report Segmented By Drug Type (Macrolide Antibiotics, Third Generation Cephalosporin, Tetracycline Antibiotics, Fluoroquinolones Antibiotics, Aminoglycoside, Aminocyclitol), By Route of Administration (Oral, Intra Muscular), By Therapy Type (Mono Therapy, Dual Therapy), & by Region – https://www.factmr.com/report/3761/gonorrhea-therapeutics-market

According to the study, azithromycin will continue to account for greater gains in the gonorrhea treatment market, closely trailed by the third-generation cephalosporin that are increasing gaining traction. Azithromycin sales for the treatment of gonorrhea are expected to hold ~50% market shares. Sales of third-generation cephalosporin are expected to grow at a rate similar to that of azithromycin in the foreseeable future. As some countries turn to increasing the doses of the recommended gonorrhea drugs in an attempt to overcome the bacteria’s resistance, the demand for macrolide antibiotics and third-generation cephalosporin is likely to grow steadily in coming years.

According to the Fact.MR study, lucrativeness of developed markets – North America and Europe – for gonorrhea therapeutics will endure, primarily underpinned by growing prevalence of STDs and rapidly advancing healthcare infrastructure in these regions. In the US alone, ~1 Mn cases of gonorrhea are reported annually, according to recent studies. Favorable reimbursement policies and government funding to numerous health organizations for the development of drug-resistant gonorrhea treatment will remain the key growth influencers of the market in these regions.

The study further opines that companies in gonorrhea therapeutics market are making bulk investments in building a robust pipeline, while focusing on drug approvals in different regions. However, the overall reluctance of gonorrhea drug manufacturing in line with long regulatory processes and complications associated with eventual antibiotic resistance of drugs could team up against the steady growth of gonorrhea therapeutics market.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=3761

This study provides a long-term outlook of the gonorrhea therapeutics market for the period, 2019 to 2029. The gonorrhea therapeutics market is estimated to register a CAGR of ~4 through 2029.

• 

Fact.MR’s Report on Global Ovarian Cancer Diagnostics Market

In a recent business intelligence study, Fact.MR presents the nitty-gritty of the global ovarian cancer diagnostics market considering 2012-2016 as the historic year and 2017–2022 as the stipulated timeframe. The business report highlights the drivers, restraints, opportunities and trends affecting market growth. Further, all the market shares associated with the market as well as the segments are expressed in terms of value and volume.

The ovarian cancer diagnostics market study outlines the key regions – North America, Latin America, Europe, Japan, APEJ and MEA – along with the countries contributing the most in the respective regions. The report presents detailed insights about each market player, including SWOT analysis, main market information, market share, revenue, pricing and gross margin. Prominent players covered in this research are Quest Diagnostics Incorporated, Myriad Genetics Inc., AstraZeneca plc., Epigenomics AG, Illumina, Inc., Bio-Rad Laboratories, Inc., Siemens AG, Thermo Fisher Scientific Inc., Roche Holding AG., and Abbott Laboratories.

As scientists in cancer research organizations continue to develop more advanced diagnosis tests for ovarian cancer, medical device manufacturers are expected to face challenges in adapting to such changes. In the long run, the demand for ovarian cancer diagnostics is expected to gain traction, on the account of rising awareness of ovarian cancer symptoms and higher adoption of screening tests as a preventive measure.

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=51

The Fact.MR report on global ovarian cancer diagnostics market projects that by the end of 2017, around US$ 638 Mn worth of revenues will be procured globally through diagnosis of ovarian cancer. Emergence of multi-purpose diagnosis tests on ovarian cancer is expected to boost the market’s expansion in the future. Towards the end of 2022, the global market for ovarian cancer diagnostics is anticipated to expand at 8.7% CAGR, bringing in revenues worth a little over US$ 966 Mn.

The ovarian cancer diagnostics market report addresses the below-mentioned queries:

• Why are vendors shifting away from traditional methods of manufacturing ovarian cancer diagnostics market?
• How does the global ovarian cancer diagnostics market looks like in the next five years?
• Which end use industry is expected to surpass segment by the end of 2022?
• What innovative products are being introduced by the players in the global ovarian cancer diagnostics market?
• Which regions are showing the fastest market growth?

On the basis of end user, the ovarian cancer diagnostics market study consists of

• Hospital Associated Labs
• Independent Diagnostic Laboratories
• Cancer Research Institutes

On the basis of cancer type, the ovarian cancer diagnostics market study incorporates:

• Epithelial Tumors
• Germ cell carcinoma tumors
• Stromal carcinoma tumors

Crucial insights in the ovarian cancer diagnostics market research:

• Underlying macro- and microeconomic factors impacting the growth of the ovarian cancer diagnostics market.
• Basic overview of the ovarian cancer diagnostics market, including market definition, classification, and applications.
• Scrutinization of each ovarian cancer diagnostics market player based on mergers & acquisitions, R&D projects, and product launches.
• Adoption trend of ovarian cancer diagnostics market across various industries.
• Important regions and countries offering lucrative opportunities to ovarian cancer diagnostics market stakeholders.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=51

Reasons to choose Fact.MR:

• Exhaustive research regarding the market to offer A to Z information.
• Digital technologies to provide innovative business solutions to the clients.
• 24/7 availability of services.
• Interaction with suppliers, vendors, and service providers for precise market landscape.
• Reports tailored as per the requirements of the clients.

• 

With a multi-disciplinary approach, Fact.MR elaborates an extensive analysis of the historical, current and future outlook of the global syringes market as well as the factors responsible for such a growth. Our highly dedicated professionals have inputted critical and accurate insights associated with every industry, and region by doing thorough primary and secondary research.

Going forward, a majority of medical procedures in the global healthcare industry will be performed through invasive techniques. The demand for syringes will continue to prevail in the years to come, urging syringe manufacturers remain optimistic. Pivotal importance of syringes as a product in the surgicals industries is expected to remain intact. Fact.MR projects that in 2017, more than US$ 11.3 Bn will be spend by patients, hospitals and other end-users for buying syringes.

In addition to this, rising demand for multifunctional syringes will also shape the dynamics of global syringes market in the future. By the end of 2022, the global market for syringes will have expanded at a robust CAGR of 7.8%, recording an estimated revenues of US$ 16.5 Bn. Following insights are excerpted from this report, which offers key projections on the growth of global syringes market during 2017-2022.

Competitive Assessment

The syringes market report includes global as well as emerging players:

• Codan Medizinische Geräte GmbH & Co Kg
• Smiths Group plc
• Medtronic PLC
• Schott AG
• Nipro Corporation
• Terumo Corporation
• Hindustan Syringes & Medical Devices Limited
• Gerresheimer AG
• Braun Melsungen AG
• Becton, Dickinson and Company

The insights for each vendor consists of:

• Company profile
• SWOT analysis
• Main market information
• Market share
• Revenue, pricing and gross margin

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=59

Regional Analysis

Important regions covered in the syringes market report include:

• MEA (Israel, Nigeria)
• APEJ (Thailand, Singapore)
• Europe (U.K., France)
• Latin America (Argentina, Mexico)

The syringes market report also provides data regarding the key countries in the defined regions.

Segmentation Analysis

By End User:

• Hospital
• Blood Collection Centers
• Diabetic Care Centers
• Veterinary Care Centers

By Product Type:

• General
• Specialized
• Conventional
• Safety
• Retractable

What insights does the syringes market report provide to the readers?

• Syringes market fragmentation on the basis of product type, end use, and region.
• Comprehensive assessment of upstream starting materials, downstream demand, and present market landscape.
• Collaborations, R&D projects, acquisitions, and product launches of each syringes market player.
• Various regulations imposed by the governments on the consumption of syringes market in detail.
• Impact of modern technologies, such as big data & analytics, artificial intelligence, and social media platforms on the global syringes market.

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=59

Questionnaire answered in the syringes market report include:

• How the market for syringes market has grown over the historic period of 2012-2016?
• What is the present and future outlook of the global syringes market on the basis of region?
• What are the challenges and opportunities for the syringes market?
• Why the consumption of syringes market highest in region?
• In which year segment is expected to overtake segment?

• 

The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end.

The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years. Various off-label drugs including tricyclic antidepressants, antihistamines, anticonvulsants, selective serotonin reuptake inhibitors, anti-anxiety drugs, and steroids are being increasingly utilized for managing symptoms of pain. Symptom management associated with pain has now become convenient and easy, owing to widely available OTC analgesics, which are prescribed with approved drugs, implied as maintenance therapies.

High potential has been observed for the market growth of OTC analgesics around the world, wherein demand as well as sales of pain medication including pain relievers, and pain killers, are gaining higher popularity among consumers. In addition, demand for the non-narcotic pain medications has been rising significantly, owing to ill effects of consuming narcotic drugs. These factors are expected to influence growth of the global market for OTC analgesics in the upcoming years. Topical analgesic distributors as well as manufacturers are concentrating on enhancing their product portfolio, with an aim to benefit from potential growth opportunities in developing as well as developed markets.

The aforementioned factors will augment the growth of global OTC analgesics market. Usually, OTC analgesic drugs are bought in large quantities, as these drugs are used for relieving different types of pain. Emergence of healthcare reforms, coupled with favorable regulatory norms across the globe, have been encouraging the uptake and initiations of various pain management programs, with an aim to lower the entire healthcare costs. These instances are estimated to pave ways for development of effective OTC analgesics.

The OTC analgesics market report highlights the following players:

• Sanofi-Aventis
• Allergen
• Bristol-Myers Squib Co
• Merck & Co.
• Procter & Gamble Co.
• Prestige Brands Holdings, Inc.
• Pfizer Inc.
• Sun Pharmaceutical Industries Ltd.
• AstraZaneca Plc.
• Novartis AG
• GlaxoSmithKline Plc.
• Johnson & Johnson Service, Inc.
• Reckitt Benckiser Group Plc.

The OTC analgesics market report examines the operating pattern of each player – new product launches, partnerships, and acquisitions – has been examined in detail.

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=75

Important regions covered in the OTC analgesics market report include:

• MEA (South Africa, Nigeria)
• APEJ (China, India)
• Europe (U.K., France)
• North America (U.S., Canada)

The OTC analgesics market report takes into consideration the following segments by product form:

• Liquid
• Capsule
• Tablet

The OTC analgesics market report contain the following OTC Channel:

• Pharmacy
• Drug Store
• Modern Trade
• Online Store

The OTC analgesics market report offers a plethora of insights which include:

• Changing consumption pattern among individuals globally.
• Historical and future progress of the global OTC analgesics market.
• Region-wise and country-wise segmentation of the OTC analgesics market to understand the revenue, and growth lookout in these areas.
• Accurate Year-on-Year growth of the global OTC analgesics market.
• Important trends, including proprietary technologies, ecological conservation, and globalization affecting the global OTC analgesics market.

The OTC analgesics market report answers important questions which include:

• Which regulatory authorities have granted approval to the application of OTC analgesics market in healthcare industry?
• How will the global OTC analgesics market grow over the forecast period?
• Which end use industry is set to become the leading consumer of OTC analgesics market by 2022?
• What manufacturing techniques are involved in the production of the OTC analgesics market?
• Which regions are the OTC analgesics market players targeting to channelize their production portfolio?

The OTC analgesics market report considers the following years to predict the market growth:

• Historic Year: 2012-2016
• Base Year: 2012
• Estimated Year: 2022
• Forecast Year: 2017 – 2022

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=75

Why Choose Fact.MR?

Fact.MR follows a multi- disciplinary approach to extract information about various industries. Our analysts perform thorough primary and secondary research to gather data associated with the market. With modern industrial and digitalization tools, we provide avant-garde business ideas to our clients. We address clients living in across parts of the world with our 24/7 service availability.

• 

The Fact.MR forecast report on global patient positioning market projects that the market will reach US$ 1.4 Bn value by the end of 2017. With improving healthcare infrastructures and adoption of ergonomic designs, manufacturers of patient positioning products are likely to boost their capacity in the years to come. Towards the end of 2022, the global market for patient positioning will have expanded steadily at 6.1% CAGR, raking revenues worth slightly over US$ 1.9 Bn.

In this patient positioning market study, the following years are considered to predict the market footprint:

• History Year: 2012-2016
• Base Year: 2012
• Estimated Year: 2022
• Forecast Year: 2017-2022

The business intelligence study of the patient positioning market covers the estimation size of the market both in terms of value (Mn/Bn USD) and volume (x units). In a bid to recognize the growth prospects in the patient positioning market, the market study has been geographically fragmented into important regions that are progressing faster than the overall market. Each segment of the patient positioning market has been individually analyzed on the basis of pricing, distribution, and demand prospect for the following regions:

• MEA (South Africa, Nigeria)
• APEJ (India, Malaysia)
• Europe (Germany, France)
• Latin America (Brazil, Mexico)

Request for the Sample of the Report: https://www.factmr.com/connectus/sample?flag=S&rep_id=52

The key players in the global patient positioning market report consist of

• Hill-Rom, Inc.
• Stryker Corporation
• STERIS plc
• Span-America Medical Systems, Inc
• Skytron
• Elekta AB(publ)
• C-RAD
• LEONI AG
• Mizuho OSI

Each market player encompassed in the patient positioning market study is assessed according to its market share, production footprint, current launches, agreements, ongoing R&D projects, and business tactics. In addition, the patient positioning market study scrutinizes the strengths, weaknesses, opportunities and threats (SWOT) analysis.

On the basis of application, the global patient positioning market report covers the footprint, and consumption of the segments including

• Surgery
• Diagnostics & Imaging
• Cancer Therapy

The global patient positioning market covers the demand trends of each end user which includes

• Hospitals
• Ambulatory Surgical Centers
• Diagnostic Centers

What insights readers can gather from the patient positioning market report?

• A critical study of the patient positioning market on the basis of end user, application and region.
• Learn the behavior pattern of every patient positioning market player – product launches, expansions, collaborations and acquisitions in the market currently.
• Examine and study the progress outlook of the global patient positioning market landscape, which includes, revenue, production & consumption and historical & forecast.
• Understand important drivers, restraints, opportunities, and trends (DROT Analysis).
• Important trends, such as carbon footprint, R&D developments, prototype technologies, and globalization.

The patient positioning market report answers the following queries:

1. Which players hold the significant patient positioning market share and why?
2. What strategies are the patient positioning market players forming to gain a competitive edge?
3. Why region is expected to lead the global patient positioning market?
4. What factors are negatively affecting the patient positioning market growth?
5. What will be the value of the global patient positioning market by the end of 2022?

Request for Report Methodology: https://www.factmr.com/connectus/sample?flag=RM&rep_id=52

Why Choose Fact.MR?

1. Deliver updated information on the current industry trends
2. Available 24/7 to facilitate clients with unbiased solutions
3. Embrace digital technologies to offer accurate business ideas
4. Exhaustive supply chain augmentation analysis
5. Provide reports strictly according to the requirements of the clients